TCR2 Therapeutics Inc. (TCRR)

AI Score

Unlock

1.48

0.00 (0.00%)

At close: May 31, 2023, 8:00 PM

TCR2 Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017
Period Ending	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-165.8M	-153.5M	-119.66M	-114.79M	-107.31M	-99.7M	-90.69M	-81.64M	-74.07M	-68.7M	-63.7M	-61.41M	-56.83M	-51.38M	-46.25M	-38.45M	-33.12M	-26.45M	-22.05M	-14.96M	-8.15M	-4.04M
Interest Income	2.93M	1.94M	963K	491K	193K	76K	229K	491K	990K	1.74M	1.55M	1.25M	747K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-162.87M	-151.56M	-118.73M	-114.34M	-107.13M	-99.52M	-90.31M	-81M	-72.96M	-66.96M	-61.31M	-58.23M	-53.07M	-47.5M	-42.46M	-35.04M	-30.17M	-24.25M	-20.57M	-14.19M	-8M	-4.01M
Net Income	-163.1M	-151.82M	-119.06M	-114.71M	-107.42M	-99.81M	-90.52M	-81.2M	-73.13M	-67.12M	-61.5M	-58.38M	-53.2M	-47.6M	-42.46M	-35.04M	-30.17M	-24.25M	-20.57M	-14.19M	-8M	-4.01M
Selling & General & Admin	26.32M	24.44M	23.84M	23.49M	23.16M	22.5M	21.57M	19.97M	18.12M	16.72M	16.63M	15.78M	15.28M	13.89M	11.94M	10.12M	8.45M	6.78M	5.85M	4.14M	2.51M	1.29M
Research & Development	105.56M	99.18M	95.85M	91.34M	84.2M	77.24M	69.13M	61.67M	55.95M	51.98M	47.07M	45.63M	41.55M	37.49M	34.31M	28.33M	24.67M	19.67M	16.2M	10.81M	5.64M	2.75M
Other Expenses	34.46M	30.42M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	131.88M	123.62M	119.69M	114.83M	107.35M	99.74M	90.69M	81.64M	74.07M	68.7M	63.7M	61.41M	56.83M	51.38M	46.25M	38.45M	33.12M	26.45M	22.05M	14.96M	8.15M	4.04M
Interest Expense	7.27M	415K	415K	415K	117K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	131.88M	123.62M	119.69M	114.83M	107.35M	99.74M	90.69M	81.64M	74.07M	68.7M	63.7M	61.41M	56.83M	51.38M	46.25M	38.45M	33.12M	26.45M	22.05M	14.96M	8.15M	4.04M
Income Tax Expense	228K	261K	325K	366K	289K	289K	204K	193K	170K	161K	188K	1.25M	2.3M	3.14M	3.79M	3.4M	2.95M	2.2M	1.48M	774K	152K	25K
Shares Outstanding (Basic)	39.22M	38.81M	38.62M	38.57M	38.51M	38.29M	38.2M	38.18M	37.06M	33.45M	30.34M	24.08M	24.01M	23.96M	23.87M	23.82M	12.33M	23.19M	15.01M	15.01M	15.01M	15.01M
Shares Outstanding (Diluted)	39.22M	38.81M	38.62M	38.57M	38.51M	38.29M	38.2M	38.18M	37.06M	33.45M	30.34M	24.08M	24.01M	23.96M	23.87M	23.82M	12.33M	23.19M	15.01M	15.01M	15.01M	15.01M
EPS (Basic)	-4.2	-3.93	-3.09	-2.99	-2.81	-2.63	-2.46	-2.33	-2.36	-2.43	-2.42	-2.44	-2.23	-2.38	-2.17	-2.02	-1.97	-1.44	-1.38	-0.95	-0.54	-0.27
EPS (Diluted)	-4.2	-3.93	-3.09	-2.99	-2.81	-2.63	-2.46	-2.33	-2.36	-2.43	-2.42	-2.44	-2.23	-2.38	-2.17	-2.02	-1.97	-1.44	-1.38	-0.95	-0.54	-0.27
EBITDA	-95.75M	-91.43M	-116.5M	-111.72M	-104.22M	-96.69M	-87.86M	-78.88M	-71.16M	-65.37M	-59.89M	-56.99M	-52.04M	-46.63M	-41.79M	-34.51M	-29.69M	-23.83M	-20.19M	-13.92M	-7.85M	-3.94M
EBIT	-125.42M	-120.97M	-60.14M	-60.14M	-28.97M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	70.06M	62.07M	3.15M	3.03M	3.02M	2.83M	2.45M	2.12M	1.8M	1.59M	1.42M	1.24M	1.03M	862K	674K	531K	478K	419K	379K	264K	152K	76K